Firm fixed price award
Ended Awarded Last action
- Contract number
- 75F40126F19019
- Awardee
-
Kaiva Strategies, LLC UEI HCWKVFGBPA64
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $73,548
Award facts
- Opportunity
-
- HFN2026132501 Solicitation number
- Contract value 100% obligated
- $73,547.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Competitive 8(a)
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration (FDA) awarded a firm fixed price delivery order valued at $73,547.61 to Kaiva Strategies, LLC on February 25, 2026, with an ultimate completion date of September 1, 2026. This award is issued under the Professional, Administrative, and Consulting Services (PACS) Indefinite Delivery Indefinite Quantity (IDIQ) contract and carries a competitive 8(a) set-aside designation. The delivery order supports the Office of Integrated Food Safety System Partnerships, specifically tasking Kaiva Strategies to provide Food Code scientific editing and writing services to the Division of Retail Food Protection Policy, Research and Risk Assessment. Work will be performed in Silver Spring, Maryland.
Kaiva Strategies, LLC is a tribally-owned, minority-owned small business based in Ivins, Utah, that holds SBA certifications as a certified 8(a) joint venture, HUBZone-certified, and small disadvantaged business. The company has established itself as a primary service provider to the FDA, leveraging expertise in scientific writing, medical writing, regulatory support, and program management. This delivery order represents one of numerous task orders issued under the FDA's $100 million competitive 8(a) PACS IDIQ contract, through which Kaiva Strategies provides specialized professional and consulting services across multiple FDA centers and offices supporting the agency's critical public health missions.
Quick answers
Who was awarded contract 75F40126F19019?
75F40126F19019 was awarded to Kaiva Strategies, LLC by Food and Drug Administration (Department of Health and Human Services) on February 25, 2026.
How much is contract 75F40126F19019 worth?
The government has obligated $73,548 on 75F40126F19019.
Is contract 75F40126F19019 an order under another contract?
Yes. 75F40126F19019 is a delivery order under 75F40123D00021, an indefinite delivery contract.
Was contract 75F40126F19019 competed?
The extent of competition for 75F40126F19019 was full and open competition after exclusion of sources. It was set aside: Competitive 8(a).
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award